Dr. Henry Stamps, MD (he/him) is a Internist in Collierville, TN with over 18 years of experience. What is your opinion of Dr. Henry Stamps, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Henry Stamps, MD has received over $17,708 which includes payments from the following companies:
$3,673.36 from Pfizer Inc.
$1,726.13 from Merck Sharp & Dohme Corporation
$1,418.62 from Novo Nordisk Inc
$1,069.08 from Takeda Pharmaceuticals America, Inc.
$1,065.66 from Janssen Pharmaceuticals, Inc
$763.28 from Vertical Pharmaceuticals, LLC
$731.11 from AstraZeneca Pharmaceuticals LP
$695.07 from Boehringer Ingelheim Pharmaceuticals, Inc.
$632.08 from Novartis Pharmaceuticals Corporation
$453.23 from Daiichi Sankyo Inc.
$448.08 from sanofi-aventis U.S. LLC
$428.98 from Amgen Inc.
$411.93 from GlaxoSmithKline, LLC.
$385.89 from LILLY USA, LLC
$329.28 from Amarin Pharma Inc.
$297.20 from Valeant Pharmaceuticals North America LLC
$286.24 from AbbVie, Inc.
$278.60 from Salix Pharmaceuticals, Ltd
$242.69 from Takeda Pharmaceuticals U.S.A., Inc.
$238.81 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
Payments received by Dr. Henry Stamps, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!